Clarivate Analytics acquires the SequenceBase business to expand its search and analysis capabilities for the life sciences IP market


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
Derwent, a Clarivate Analytics company and world-leading IP intelligence provider, to offer sequence searching for the fast-growing biologics market.

Clarivate Analytics, a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced that it has acquired the business of SequenceBase, a leader in providing patent sequence information and search technology to the biotech, pharmaceutical and chemical industries.

The acquisition will deliver an expanded solution to the fast-growing biologics market. It complements Derwent's GENESEQ™ database and leading patent research platform Derwent Innovation™, providing users with an intuitive solution to easily search, analyze and find context in sequence data within patents. GENESEQ is a proprietary database trusted by the largest players in biologics today. It is the only database to provide annotated analysis to help simplify the complexity of searching and identifying biological sequences (DNA, RNA and protein sequences) covered in patents from over 50 patent issuing authorities.

Biotech advancements have made large-scale development of biological drugs easier and more cost-effective. As such, the global biologics market continues to grow1 and life science IP professionals need to be better equipped to easily search and analyze patents containing sequences. A typical new drug can cost over $2bn2 to bring to market and the acquisition of SequenceBase will allow Derwent users to find the answers they seek faster in pursuing new biologics innovation.

"The acquisition confirms our commitment to the IP life science community and will allow us to better serve our customers' growing needs for high quality, intuitive solutions for sequence-oriented patent research," said Dan Videtto, President, Derwent, Clarivate Analytics. "Through the combination of the SequenceBase platform with proprietary USGENE and WOGENE databases and GENESEQ content, customers can now better understand the sequence landscape, enabling them to quickly assess patentability, identify potential infringing patents and track competitor activities."

"SequenceBase is honored to join Derwent on its mission to be a trusted, indispensable global partner to innovators everywhere. Our team has a proven record of building essential tools for scientists that help bring their ideas to life. The combination of SequenceBase's user-friendly search interface and sequence data with Derwent's curated and enriched databases will improve the workflow of biologic researchers and IP professionals around the world," said Martin Goffman, President and CEO of SequenceBase.

Videtto concluded, "This is an exciting time for IP professionals and scientists that focus on creating truly impactful change in biologics. It is equally exciting for Clarivate and Derwent to continue to bring trusted, indispensable solutions that support the commercial success of the world's innovators."

About Derwent
Derwent™, a Clarivate Analytics company, powers the innovation lifecycle from idea to commercialization – with trusted patent data, applications and services including Derwent Innovation™, Derwent World Patents Index™, Derwent Patents Citation Index™ and Derwent Data Analyzer™. We build solutions for inventors, patent attorneys and licensing specialists at start-ups and the largest global innovators, legal professionals at the leading intellectual property practices, and patent examiners at more than 40 patent offices. Our solutions are used to monitor technology trends and competitive landscapes, inform FTO opinions, prosecute patents, monetize and license assets and support litigation activities. For more information, please visit derwent.com.

About Clarivate Analytics
Clarivate Analytics™ is a global leader in providing trusted insights and analytics to accelerate the pace of innovation. We have built some of the most trusted brands across the innovation lifecycle, including Web of Science™, Cortellis™, Derwent™, CompuMark™, MarkMonitor™ and Techstreet™. Today, Clarivate Analytics is on a bold entrepreneurial mission to help customers reduce the time from new ideas to life-changing innovations. For more information, please visit clarivate.com.

Forward-Looking Statements
This press release and oral statements included herein may contain forward-looking statements regarding Clarivate Analytics. Forward-looking statements provide Clarivate Analytics' current expectations or forecasts of future events and may include statements regarding results, anticipated synergies and other future expectations. These statements involve risks and uncertainties including factors outside of Clarivate Analytics' control that may cause actual results to differ materially. Clarivate Analytics undertakes no obligation to update or revise the statements made herein, whether as a result of new information, future events or otherwise.

Tags : #clarivate #lifesciences #innovation #aquisition #derwent

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026